Adynxx, Inc. (ADYX)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
At close: Sep 8, 2026
Adynxx Market Cap
Adynxx has a market cap or net worth of $581 as of October 16, 2026. It is the 52,508th most valuable company in the world and the 8,542nd biggest in the United States. Its market cap has increased by 9,583.33% in one year.
Market Cap
581.00
Enterprise Value
n/a
Revenue
n/a
Global Rank
Country Rank
#8,542 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since May 6, 2019, Adynxx's market cap has decreased from 52.42M to 581.00, a decrease of -100.00%. That is a compound annual growth rate of -78.83%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2026 | 581.00 | - |
| Dec 10, 2025 | 581.00 | 9,583.33% |
| Dec 30, 2024 | 6.00 | -99.48% |
| Dec 31, 2021 | 1.16K | -99.95% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 6, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| eFFECTOR Therapeutics | 941.00 |
| Proteonomix | 791.00 |
| Pathfinder Cell Therapy | 667.00 |
| U.S. Stem Cell | 662.00 |
| Amarantus BioScience Holdings | 630.00 |
| Alzex Neuropharma | 602.00 |
| GlobeImmune | 575.00 |
| Tetra Bio-Pharma | 516.00 |